Dextroamphetamine Saccharate — Class II drug recall D-0660-2026
Ongoing recall by Lannett Company Inc., reported 2026-07-08, distributed nationwide. Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.
| Recall number | D-0660-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Lannett Company Inc., Seymour, IN, United States |
| Recall initiated | 2026-06-26 |
| Classified | 2026-07-02 |
| Reported by FDA | 2026-07-08 |
| Distributed | Nationwide (US) |
| Quantity | 1,392 bottles |
| Reason classes | labeling |
| NDC | 00527-0790, 00527-0790-37, 00527-0791, 00527-0791-37, 00527-0792, 00527-0792-37, 00527-0793, 00527-0793-37, 00527-0794, 00527-0794-37, 00527-0795, 00527-0795-37 |
| Lot numbers | 25285401A |
| Expiration dates | 2027-04 |
Product
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules, 5 mg, Rx Only, 100 capsules, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC: 0527-0790-37.
Reason for recall
Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0660-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.